These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1680257)

  • 21. The mechanism of the action of Minipress. Examinations in hypertension.
    Török E; Bíró V; Podmaniczky M
    Ther Hung; 1989; 37(2):90-8. PubMed ID: 2573964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of calcium inhibitors in the treatment of arterial hypertension].
    Hrnciar J; Hrnciarová M; Jakubíková K
    Vnitr Lek; 1997 Feb; 43(2):74-80. PubMed ID: 9245072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Major new developments affecting treatment and prognosis in hypertension.
    Gubner RS
    Trans Assoc Life Insur Med Dir Am; 1990; 73():97-114. PubMed ID: 2353405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical use of calcium antagonists in hypertension: update 1986.
    Lund-Johansen P
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S29-35. PubMed ID: 2455135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of alpha inhibitors on risk cofactors in patients with hypertension].
    Plouin P
    Ann Cardiol Angeiol (Paris); 1989 Dec; 38(9 Pt 2):577-9; discussion 580. PubMed ID: 2576348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Alpha blockers and microcirculation (author's transl)].
    Cloarec M; Graisely B; Perdriset G; Dumas JR
    J Mal Vasc; 1981; 6(1):35-7. PubMed ID: 6116739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Controversies in the treatment of arterial hypertension: other drugs as the first step (calcium antagonists, ACE inhibitors and alpha-blockers)].
    Castro Beiras A; Muñiz J; Juane R
    Rev Esp Cardiol; 1995; 48 Suppl 4():72-80. PubMed ID: 7494933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
    Hansen O; Johansson BW
    J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New alpha 1-adrenergic receptor antagonists for the treatment of hypertension: role of vascular alpha receptors in the control of peripheral resistance.
    Cubeddu LX
    Am Heart J; 1988 Jul; 116(1 Pt 1):133-62. PubMed ID: 2899387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha-adrenergic blockers: mechanism of action, blood pressure control, and effects of lipoprotein metabolism.
    Nash DT
    Clin Cardiol; 1990 Nov; 13(11):764-72. PubMed ID: 1980236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha 1 blockers. Safe, effective treatment for hypertension.
    Itskovitz HD
    Postgrad Med; 1991 Jun; 89(8):89-92, 95-8, 103-6, passim. PubMed ID: 1674822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of selective alpha 1 blockers in the therapy of hypertension.
    Kaplan NM
    Am J Med; 1986 May; 80(5B):100-4. PubMed ID: 2872800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective alpha 1-adrenoreceptor blockers in the treatment of hypertension: should we be using them more?
    Ligueros M; Unwin R; Wilkins M
    Clin Auton Res; 1991 Sep; 1(3):251-8. PubMed ID: 1687998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The place of alpha blockers in the treatment of hypertension.
    Reid JL
    Clin Exp Hypertens; 1993 Nov; 15(6):1291-7. PubMed ID: 7903577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview of alpha 1-adrenoceptor antagonism and recent advances in hypertensive therapy.
    Veelken R; Schmieder RE
    Am J Hypertens; 1996 Nov; 9(11):139S-149S. PubMed ID: 8931846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Alpha-blocker].
    Miyashita Y
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():227-31. PubMed ID: 11347064
    [No Abstract]   [Full Text] [Related]  

  • 39. Alpha blockers: an effective extension to your patients' risk reduction program.
    Houston MC
    J Clin Pharmacol; 1993 Mar; 33(3):264-71. PubMed ID: 8096523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New findings on the use of specific alpha-1 adrenergic blockers in the treatment of high blood pressure].
    Horký K
    Vnitr Lek; 1991 Jun; 37(6):604-11. PubMed ID: 1680257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.